The Efficacy of Moclobemide in Treatment of Major Depression
The effectiveness and the tolerence of moclobemde -one of the reversible inhibitors of MAO-A were assessed in an open clinical trial on 19 inpatients with major depression according to DSM.III and with a score of 16 or more on Hamilton Rating Scale of Depression (HRSD). As a result, a statistically...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Mesut Çetin
2021-03-01
|
| Серія: | Psychiatry and Clinical Psychopharmacology |
| Предмети: | |
| Онлайн доступ: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/106 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|